Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Sickle Cell Disease, Biological therapies, adult, Acute Myeloid Malignancies, AML, MDS, clinical trials, Bone Marrow Failure Syndromes, Clinical Practice (Health Services and Quality), Aplastic Anemia, Clinical Research, Hemoglobinopathies, Chronic Myeloid Malignancies, pediatric, Diseases, Therapies, Lymphoid Malignancies, Adverse Events, registries, Myeloid Malignancies, Study Population, Human, Transplantation
Type: Oral
Hematology Disease Topics & Pathways:
Research, Sickle Cell Disease, Biological therapies, adult, Acute Myeloid Malignancies, AML, MDS, clinical trials, Bone Marrow Failure Syndromes, Clinical Practice (Health Services and Quality), Aplastic Anemia, Clinical Research, Hemoglobinopathies, Chronic Myeloid Malignancies, pediatric, Diseases, Therapies, Lymphoid Malignancies, Adverse Events, registries, Myeloid Malignancies, Study Population, Human, Transplantation
Monday, December 12, 2022: 4:30 PM-6:00 PM
260-262
(Ernest N. Morial Convention Center)
Moderators:
Joseph Maakaron, MD, University of Minnesota
and
Filippo Milano, MD, Fred Hutchinson Cancer Center
Disclosures:
Maakaron: ADC Therapeutics: Research Funding; Gilead: Research Funding; CRISPR Therapeutics: Research Funding; Precision Biosciences: Research Funding.
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH